Allero Therapeutics

About:

Allero Therapeutics is a biopharmaceutical company.

Website: https://www.allerotherapeutics.com/

Top Investors: European Innovation Council, EASME - EU Executive Agency for SMEs, Swanbridge Capital

Description:

Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders. Based on research by the founders and their collaborators the team has identified a novel specific immunotherapy approach based on antigen-specific tolerance induction. The approach defines a platform technology which is broadly applicable to a range of clinical indications with profound unmet medical need.